
Ivatri 7.5mg Tablet
Marketer
ANT Pharmaceuticals Pvt Ltd
Salt Composition
Ivabradine (7.5mg)
Overview Ivatri 7.5mg Tablet
Ivatri 7.5mg tablets are prescribed for angina pectoris (chest pain stemming from heart conditions) and long-standing congestive heart failure. Its mechanism improves cardiac efficiency by reducing heart rate, thus mitigating chest discomfort and reducing hospital readmissions for heart failure patients. Dosage varies depending on the specific condition. As treatment is typically ongoing, cessation requires prior consultation with your physician. Consistent daily ingestion with food is recommended. Overdose may cause bradycardia (excessively slow heart rate), fatigue, and shortness of breath; seek immediate medical counsel if this occurs. Common, usually transient, adverse effects include visual disturbances, bradycardia, hypertension, atrial fibrillation, vertigo, blurred vision, and electrocardiographic alterations. However, serious reactions like syncope (fainting) and pronounced heart rhythm changes necessitate prompt medical attention. Refrain from operating vehicles until the drug's effects are known. Contraindicated in patients with severe hepatic impairment, pre-existing bradycardia, arrhythmias, significantly low blood pressure, or recently exacerbated heart failure. It also interacts negatively with certain antihypertensives, antifungals, and antiretroviral medications. Its use is prohibited during pregnancy, attempts at conception, and lactation.
Primary Ingredients of Ivatri 7.5mg Tablet
No information provided. Please provide the text you wish me to rephrase.
Uses of Ivatri 7.5mg Tablet
Managing angina pectoris and heart failure.
Major Benefits of Ivatri 7.5mg Tablet:
Consume this medication according to your physician's prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Ivatri 7.5mg Tablet should be administered with a meal.
Common Side effects of Ivatri 7.5mg Tablet:
- Slow heart rate
- Luminous phenomena (Enhanced brightness)
- High blood pressure
- Atrial fibrillation
- Dizziness
- Blurred vision
- ECG changes
How to use Ivatri 7.5mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the 7.5mg Ivatri tablet whole; avoid chewing, crushing, or fracturing it. Take it with a meal.
How Ivatri 7.5mg Tablet works:
Ivatri 7.5mg tablets decrease cardiac rate. This medication achieves its effect by slowing the heart's rhythm, thereby diminishing the organ's oxygen demand and improving its overall performance.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Ivatri 7.5mg Tablet may pose unknown risks. Seek medical advice before combining them.
PregnancyUNSAFE
Using Ivatri 7.5mg tablets during pregnancy poses a substantial risk. Pregnant individuals should consult their physician, as research in animals and pregnant women has revealed significant adverse effects on fetal development.
Breast feedingUNSAFE
Lactation and Ivatri 7.5mg tablets are incompatible. Evidence indicates potential infant toxicity from this medication.
DrivingUNSAFE
Driving ability may be impaired by Ivatri 7.5mg Tablet, which can induce transient visual disturbances, primarily phosphenes. Night driving should be considered carefully due to the potential for these light flashes.
KidneyCAUTION
Patients with severe kidney impairment should use Ivatri 7.5mg Tablets cautiously, as dose modification may be necessary. Physician consultation is advised due to limited data on Ivatri 7.5mg Tablet use in this patient population.
LiverCAUTION
Patients with liver impairment should use Ivatri 7.5mg tablets cautiously, potentially requiring dosage modification under medical supervision. Ivatri 7.5mg tablets are contraindicated in those with severe hepatic dysfunction.
What if you forget to take Ivatri 7.5mg Tablet :
Omit any missed Ivatri 7.5mg Tablet dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Ivatri 7.5mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Benzazepine compound |
| Developing Habits | No. |
| Treatment Category | Heart |
| Actions | Sodium channel blockers targeting the sinoatrial node |
